Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Canadian Pacific Kansas City Limited Common SharesTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

Canadian Pacific Kansas City Limited Common Shares vs Ginkgo Bioworks Holdings Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.56 (market cap $73.98B), while Ginkgo Bioworks Holdings Inc trades at $12.95 (market cap $763.64M). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 96.9× Ginkgo Bioworks Holdings Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.

CPDNA
Market Cap
$73.98B$763.64M
Volume
1,669,8283,204,177
Sector
IndustrialsHealth
52-Week High
$96.69$15.83
52-Week Low
$68.88$5.48
Enterprise Value
$91.36B$865.59M
Dividend Yield
0.9%—
Typical Hold Time
—7 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canadian Pacific Kansas City Limited Common Shares

No Aura AI signal available yet.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.04, up 13.69% in the last session, with a bullish technical signal from moving averages. The company maintains strong gross margins at 68.04% but faces significant losses with a -219.6% net income margin. Recent developments include a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnerships expanding genetic testing distribution.

While technical momentum appears positive, fundamental challenges persist with substantial cash burn and declining revenue projections. Analyst sentiment is divided equally between buy, hold, and sell ratings. Investment opportunity lies in the company's strategic partnerships and government contracts, balanced against ongoing profitability concerns and competitive pressures in biotech.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CP

No sentiment data available yet.

DNA
47% Buy53% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About Canadian Pacific Kansas City Limited Common Shares

Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.

Read more on CP →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →